10 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·04/17/2026 17:05:58
Listen to the news
Gainers
Psyence Biomedical (NASDAQ:PBM) shares increased by 40.5% to $8.25 during Friday's regular session. The market value of their outstanding shares is at $6.0 million.
InflaRx (NASDAQ:IFRX) stock increased by 25.85% to $1.51. The market value of their outstanding shares is at $81.2 million.
Forum Markets (NASDAQ:FRMM) stock moved upwards by 22.78% to $2.91. The company's market cap stands at $48.1 million.
Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock increased by 22.35% to $0.11.
Aprea Therapeutics (NASDAQ:APRE) shares increased by 20.63% to $1.09. The company's market cap stands at $10.3 million.
Candel Therapeutics (NASDAQ:CADL) stock rose 19.47% to $6.17. The market value of their outstanding shares is at $377.9 million.
Losers
Enveric Biosciences (NASDAQ:ENVB) shares fell 23.3% to $1.8 during Friday's regular session. The company's market cap stands at $3.2 million.
Clearmind Medicine (NASDAQ:CMND) shares declined by 13.57% to $0.72. The market value of their outstanding shares is at $1.9 million.
Aligos Therapeutics (NASDAQ:ALGS) shares decreased by 12.54% to $6.7. The market value of their outstanding shares is at $47.3 million.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.